The CD28-TMDM4, but not the other TMD-mutants, abrogated the proliferation of CD3−CARlow cells and significantly reduced the proliferation of CD3−CARint cells with either CD8-HD or IgG4-HD (Figures 3B,C). Here, CD8A is linked to Huntington disease.